Acepodia (ROCO:6976) Beneish M-Score: 15.27 (As of Jul. 28, 2026) — 90% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6976 Acepodia Inc ROCO:6976
11 GF Score
Price NT$12.60
! 3 Warning Signs
View Full Analysis

What is Acepodia Beneish M-Score?

Acepodia ROCO:6976 +0.80% 11 Beneish M-Score is 15.27 as of Jul. 28, 2026, which is 90% below its 10-year median of 154.62. GuruFocus rates ROCO:6976 with a GF Score™ of 11/100. The stock has 3 warning signs investors should review. Among 825 Biotechnology companies, Acepodia ranks worse than 94.91% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 15.27 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Acepodia's Beneish M-Score or its related term are showing as below:

ROCO:6976' s Beneish M-Score Range Over the Past 10 Years
Min: 15.27   Med: 154.62   Max: 293.96
Current: 15.27

During the past 6 years, the highest Beneish M-Score of Acepodia was 293.96. The lowest was 15.27. And the median was 154.62.


Acepodia Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Acepodia's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Acepodia Beneish M-Score Chart

Acepodia Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial 0.00 0.00 0.00 293.96 15.27

Acepodia Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 293.96 0.00 15.27

ROCO:6976 vs VRTX, REGN, RVMD: Beneish M-Score Comparison

For the Biotechnology subindustry, Acepodia's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Acepodia Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Acepodia's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Acepodia's Beneish M-Score falls into.


ROCO:6976
11GF Score
Acepodia Inc ROCO:6976
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Acepodia Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Acepodia for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 3.2612+0.528 * 0.9954+0.404 * 41.9117+0.892 * 0.4333+0.115 * 0.6806
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 2.5784+4.679 * -0.00808-0.327 * 1.0081
=15.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was NT$31.46 Mil.
Revenue was NT$0.19 Mil.
Gross Profit was NT$0.12 Mil.
Total Current Assets was NT$3,944.53 Mil.
Total Assets was NT$5,833.41 Mil.
Property, Plant and Equipment(Net PPE) was NT$534.90 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$115.21 Mil.
Selling, General, & Admin. Expense(SGA) was NT$162.57 Mil.
Total Current Liabilities was NT$194.43 Mil.
Long-Term Debt & Capital Lease Obligation was NT$207.28 Mil.
Net Income was NT$-754.40 Mil.
Gross Profit was NT$0.00 Mil.
Cash Flow from Operations was NT$-707.27 Mil.
Total Receivables was NT$22.26 Mil.
Revenue was NT$0.43 Mil.
Gross Profit was NT$0.28 Mil.
Total Current Assets was NT$6,193.43 Mil.
Total Assets was NT$6,819.32 Mil.
Property, Plant and Equipment(Net PPE) was NT$588.13 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$80.67 Mil.
Selling, General, & Admin. Expense(SGA) was NT$145.52 Mil.
Total Current Liabilities was NT$206.07 Mil.
Long-Term Debt & Capital Lease Obligation was NT$259.75 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(31.458 / 0.185) / (22.264 / 0.427)
=170.043243 / 52.140515
=3.2612

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(0.278 / 0.427) / (0.121 / 0.185)
=0.651054 / 0.654054
=0.9954

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (3944.529 + 534.902) / 5833.407) / (1 - (6193.426 + 588.131) / 6819.324)
=0.232107 / 0.005538
=41.9117

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=0.185 / 0.427
=0.4333

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(80.667 / (80.667 + 588.131)) / (115.211 / (115.211 + 534.902))
=0.120615 / 0.177217
=0.6806

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(162.566 / 0.185) / (145.522 / 0.427)
=878.735135 / 340.800937
=2.5784

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((207.28 + 194.432) / 5833.407) / ((259.748 + 206.067) / 6819.324)
=0.068864 / 0.068308
=1.0081

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-754.401 - 0 - -707.266) / 5833.407
=-0.00808

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Acepodia has a M-score of 15.27 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of 15.27 mean?
Acepodia (ROCO:6976) has a Beneish M-Score of 15.27 as of Jul. 28, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Acepodia and its competitors. This is 90% below median its historical median of 154.62. Over the past decade, Acepodia's Beneish M-Score has ranged from 15.27 to 293.96. According to the industry distribution chart, Acepodia ranks #783 out of 825 companies in the Biotechnology industry, placing it in the top 94.9%.
Is Acepodia's Beneish M-Score too high?
Acepodia's current Beneish M-Score of 15.27 is 90% below median its 10-year median of 154.62. Over the past 10 years, this metric has ranged from a low of 15.27 to a high of 293.96. Based on the distribution chart, Acepodia ranks #783 out of 825 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Acepodia has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Acepodia's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Acepodia ranks #783 out of 825 companies for Beneish M-Score. This places Acepodia in the lower half of its industry. Historically, Acepodia's own Beneish M-Score has ranged from 15.27 to 293.96 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Acepodia and its competitors. Acepodia's current Beneish M-Score is 15.27, which is 90% below median its own 10-year median of 154.62. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Acepodia stock overvalued right now?
Acepodia (ROCO:6976) has a current Beneish M-Score of 15.27. The current Beneish M-Score is 15.27, which is 90% below median its 10-year median of 154.62. Acepodia's overall GF Score™ is 11/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Acepodia (ROCO:6976), the current Beneish M-Score is 15.27 as of Jul. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Acepodia Business Description

Address 17th floor-12, Number 99, Section 1, Xintai 5th Road, Xizhi District, New Taipei, TWN, 22175
Acepodia Inc is a clinical stage biotechnology company engaged to develop first-in-class cell therapies by using the Antibody-Cell Conjugation platform technology for cancer that are broadly accessible for patients.
11GF Score

Get the complete analysis for ROCO:6976

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$12.60
Price